BEIJING, China & GOTHENBURG, Sweden — 2025-10-24 — Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for…
Ribo granted EMA Orphan Drug Designation for siRNA therapeutic RBD1016 for hepatitis delta Virus (HDV) Infection
